SYHX2011

DRUG3 trials

Sponsors

CSPC Ouyi Pharmaceutical Co., Ltd., Shanghai Chest Hospital

Conditions

Advanced Breast CancerNon-Small Cell Lung Cancer

Phase 2

A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011

Not yet recruitingNCT06354114

CSPC Ouyi Pharmaceutical Co., Ltd.Advanced Breast Cancer

Start: 2024-04-30End: 2026-12-31Target: 80Updated: 2024-04-09

SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer

Not yet recruitingNCT07662811

Shanghai Chest HospitalNon-Small Cell Lung Cancer

Start: 2026-06-01End: 2029-12-31Target: 396Updated: 2026-06-29

Phase 3

A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

CSPC Ouyi Pharmaceutical Co., Ltd.Advanced Breast Cancer

Start: 2023-05-01End: 2024-09-01Target: 454Updated: 2023-03-03

Related Papers

Abstract PS1-09-24: Efficacy and safety of Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-blind Phase III study

Clinical Cancer Research2026-02-17